Literature DB >> 32466962

Gut microbiota differs a decade after bariatric surgery relative to a nonsurgical comparison group.

Jacob G Mabey1, John M Chaston2, Daphne G Castro2, Ted D Adams3, Steven C Hunt4, Lance E Davidson5.   

Abstract

BACKGROUND: Few studies have assessed differences in the gut microbiota composition after bariatric surgery in the long term or whether differences are correlated with remission of type 2 diabetes.
OBJECTIVES: This observational study assessed differences in the gut microbiota between individuals at up to 13 years after surgery and a comparison group of individuals with severe obesity. The relationship between type 2 diabetes remission and the gut microbiota was also assessed.
SETTING: University.
METHODS: Stool samples were collected from individuals completing bariatric surgery (surgery group; n = 16) and individuals with severe obesity that did not receive surgery (nonsurgery group; n = 19) as part of the 12-year follow-up in the Utah Obesity Study. Metabolic health data were collected at baseline and the follow-up examination. The gut microbiota was quantified by sequencing the V4 region of the 16 S rRNA gene. Significant differences in microbiota composition with surgery and other covariates were determined by Unifrac distance analysis and permutational multivariate analysis of variance. Significant differences in the relative abundance of individual bacterial taxa were assessed using analysis of composition of microbiomes software.
RESULTS: The surgery group had higher relative abundances of Verrucomicrobiaceae (5.7 ± 1.3% versus 1.1 ± .3%) and Streptococcaceae (6.3 ± 1.0% versus 3.2 ± .8%), but lower relative abundances of Bacteroidaceae (8.8 ± 1.8% versus 18.6 ± 2.3%) 10.6 years after surgery. In a small subset of 8 individuals, a higher relative abundance of Akkermansia muciniphila was correlated with type 2 diabetes remission.
CONCLUSIONS: Differences in the gut microbiota are evident a decade after bariatric surgery compared with individuals with severe obesity that did not undergo surgery. The observed long-term differences are consistent with previous findings.
Copyright © 2020 American Society for Bariatric Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Akkermansia muciniphila; Bariatric surgery; Gut microbiota; Long-term follow-up; Type 2 diabetes remission; Utah Obesity Study

Mesh:

Year:  2020        PMID: 32466962      PMCID: PMC7483956          DOI: 10.1016/j.soard.2020.04.006

Source DB:  PubMed          Journal:  Surg Obes Relat Dis        ISSN: 1550-7289            Impact factor:   4.734


  43 in total

1.  Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery.

Authors:  Lars Sjöström; Anna-Karin Lindroos; Markku Peltonen; Jarl Torgerson; Claude Bouchard; Björn Carlsson; Sven Dahlgren; Bo Larsson; Kristina Narbro; Carl David Sjöström; Marianne Sullivan; Hans Wedel
Journal:  N Engl J Med       Date:  2004-12-23       Impact factor: 91.245

2.  Development of a dual-index sequencing strategy and curation pipeline for analyzing amplicon sequence data on the MiSeq Illumina sequencing platform.

Authors:  James J Kozich; Sarah L Westcott; Nielson T Baxter; Sarah K Highlander; Patrick D Schloss
Journal:  Appl Environ Microbiol       Date:  2013-06-21       Impact factor: 4.792

3.  Differential Changes in Gut Microbiota After Gastric Bypass and Sleeve Gastrectomy Bariatric Surgery Vary According to Diabetes Remission.

Authors:  Rinki Murphy; Peter Tsai; Mia Jüllig; Amy Liu; Lindsay Plank; Michael Booth
Journal:  Obes Surg       Date:  2017-04       Impact factor: 4.129

4.  An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice.

Authors:  Na-Ri Shin; June-Chul Lee; Hae-Youn Lee; Min-Soo Kim; Tae Woong Whon; Myung-Shik Lee; Jin-Woo Bae
Journal:  Gut       Date:  2013-06-26       Impact factor: 23.059

5.  Design and rationale of the Utah obesity study. A study to assess morbidity following gastric bypass surgery.

Authors:  Ted D Adams; Erick Avelar; Tom Cloward; Ross D Crosby; Robert J Farney; Richard Gress; R Chad Halverson; Paul N Hopkins; Ronette L Kolotkin; Michael J Lamonte; Sheldon Litwin; Robert T Nuttall; Robert Pendleton; Wayne Rosamond; Steven C Simper; Sherman C Smith; Michael Strong; James M Walker; Gail Wiebke; Frank G Yanowitz; Steven C Hunt
Journal:  Contemp Clin Trials       Date:  2005-10       Impact factor: 2.226

6.  Roux-en-Y Gastric Bypass: A 7-year Retrospective Review of 3,855 Patients.

Authors: 
Journal:  Obes Surg       Date:  1995-08       Impact factor: 4.129

7.  Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology.

Authors:  Maria Carlota Dao; Amandine Everard; Judith Aron-Wisnewsky; Nataliya Sokolovska; Edi Prifti; Eric O Verger; Brandon D Kayser; Florence Levenez; Julien Chilloux; Lesley Hoyles; Marc-Emmanuel Dumas; Salwa W Rizkalla; Joel Doré; Patrice D Cani; Karine Clément
Journal:  Gut       Date:  2015-06-22       Impact factor: 23.059

8.  Metformin Is Associated With Higher Relative Abundance of Mucin-Degrading Akkermansia muciniphila and Several Short-Chain Fatty Acid-Producing Microbiota in the Gut.

Authors:  Jacobo de la Cuesta-Zuluaga; Noel T Mueller; Vanessa Corrales-Agudelo; Eliana P Velásquez-Mejía; Jenny A Carmona; José M Abad; Juan S Escobar
Journal:  Diabetes Care       Date:  2016-11-14       Impact factor: 19.112

9.  Human gut microbiota in obesity and after gastric bypass.

Authors:  Husen Zhang; John K DiBaise; Andrea Zuccolo; Dave Kudrna; Michele Braidotti; Yeisoo Yu; Prathap Parameswaran; Michael D Crowell; Rod Wing; Bruce E Rittmann; Rosa Krajmalnik-Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-21       Impact factor: 11.205

10.  Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota.

Authors:  Kristoffer Forslund; Falk Hildebrand; Trine Nielsen; Gwen Falony; Emmanuelle Le Chatelier; Shinichi Sunagawa; Edi Prifti; Sara Vieira-Silva; Valborg Gudmundsdottir; Helle K Pedersen; Manimozhiyan Arumugam; Karsten Kristiansen; Anita Yvonne Voigt; Henrik Vestergaard; Rajna Hercog; Paul Igor Costea; Jens Roat Kultima; Junhua Li; Torben Jørgensen; Florence Levenez; Joël Dore; H Bjørn Nielsen; Søren Brunak; Jeroen Raes; Torben Hansen; Jun Wang; S Dusko Ehrlich; Peer Bork; Oluf Pedersen
Journal:  Nature       Date:  2015-12-02       Impact factor: 49.962

View more
  2 in total

Review 1.  The Gut/Lung Microbiome Axis in Obesity, Asthma, and Bariatric Surgery: A Literature Review.

Authors:  Yeon Ji Kim; Jack T Womble; Claudia K Gunsch; Jennifer L Ingram
Journal:  Obesity (Silver Spring)       Date:  2021-04       Impact factor: 5.002

Review 2.  Gut microbiome and microbial metabolites in NAFLD and after bariatric surgery: Correlation and causality.

Authors:  Yi Xia; Mengting Ren; Jinpu Yang; Changzhou Cai; Weixin Cheng; Xinxin Zhou; Dan Lu; Feng Ji
Journal:  Front Microbiol       Date:  2022-09-20       Impact factor: 6.064

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.